Hem › Metastaserande cancer › District of Columbia
Kliniska studier för Metastaserande cancer i District of Columbia
24 studier för Metastaserande cancer söker deltagare vid platser i District of Columbia.
Städer i District of Columbia
Officiell studietext (engelska)
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Georgetown University Hospital, Washington D.C.
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT05382559Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Georgetown University, Washington D.C.
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT06943755A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07277413ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- The George Washington Medical facility Associates, Washington D.C.
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07007559A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06989437A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Georgetown University Medical Center, Washington D.C.
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT05118789A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174336A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06863272CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
- Clinical Study Site, Washington D.C.
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 10 sep. 2026 · NCT07335497A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT06119581AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Washington D.C.
RekryterarFas 1/2
Ålder 18 till 75 · Alla kön · Uppdaterad 4 sep. 2026 · NCT07038343A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Washington D.C.
RekryterarFas 2
Ålder 18 till 130 · Alla kön · Uppdaterad 18 aug. 2026 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT05919264Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Kvinnor · Uppdaterad 29 juli 2026 · NCT07044336Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- George Washington University, Washington D.C.
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 14 juli 2026 · NCT05533697(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
- MedStar Washington Hospital Center, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 16 juni 2026 · NCT05208047A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Georgetown University Medical Center, Washington D.C.
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 27 maj 2026 · NCT05384626Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 23 apr. 2026 · NCT02333604A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- The George Washington University, Washington D.C.
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT06064877Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RekryterarFas 2/3
Ålder 18 och äldre · Män · Uppdaterad 8 apr. 2026 · NCT04787744A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Georgetown University Medical Center, Washington D.C.
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT06521554VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- The George Washington University Cancer Center (site 212), Washington D.C.
RekryterarFas 1/2
Ålder 18 till 80 · Alla kön · Uppdaterad 11 dec. 2025 · NCT03556228Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.